2016-2020 Tumor Marker Testing Market: Strategic Assessments of Current and Emerging Competitors

March 2016 | 80 pages | ID: 29B3D8CE65FEN
Venture Planning Group

Abstracts

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:

• Sales
• Product portfolios
• Distribution tactics
• Technological know-how
• New products in R&D
• Collaborative arrangements
• Business strategies.

Contains 80 pages

Contents

Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila